EmpowerPharm is developing a prescription cannabidiol (CBD), designed to be consumed orally in a solid dose format. We source our CBD API from a Canadian supplier with a GMP facility approved by Health Canada.
References:Global Social Anxiety Treatment Market, Forecast to 2030 – Infinity Business Insights NIMH: Social Anxiety Disorder.
Prescription drug to be approved in USA, Canada, and globally, allowing patients to be reimbursed by insurance companies and drug formularies
High quality standardized dosages with enhanced bioavailability and IP protection
Manufactured under GMP Standards at our own facility with a Drug Establishment Licence
Alternative anxiety treatment, not physically addictive as with benzodiazepines, and with fewer side effects than anti-depressants (SSRI/SNRI)*
T 416.291.2580 E firstname.lastname@example.org
Copyright © 2023 EmpowerPharm Inc. • All Rights Reserved